Opinion: BRAIN Is Not Enough

The recently announced BRAIN Initiative, referred to as the Apollo program for neuroscience, needs more funding and better goals to live up to the hype.

Written byAlvaro Fernandez
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

FLICKR, ADRIGUEarlier this year, President Obama kicked off the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative with great fanfare, announcing a $100 million funding grant to start a “bold new research effort” aimed at unlocking “the mystery of the three pounds of matter that sits between our ears.” This is great news for scientists who study brain function in the sense that any funding and high-level attention is a welcome addition to a comparatively underfunded, underappreciated field of study. But it’s hardly a grand national challenge on par with the Apollo and Human Genome Project to which it’s sometimes compared.

In fact, other countries are taking a much more aggressive approach to advancing brain science. In China, the Brainnetome project was launched nearly 10 years ago, and the European Union is pouring $1.5 billion into its Human Brain Project. As Máire Geoghegan-Quinn, European Commissioner for Research, Innovation and Science, recently said, “healthy brains are essen­tial for happy indi­vid­u­als and fam­i­lies, for an effi­cient work force, for inno­v­a­tive prod­ucts and ser­vices. . . . There­fore, invest­ment in brain research is an intel­li­gent invest­ment, espe­cially in times of scare resources, as it can help avoid even higher costs to soci­ety in the future.”

Indeed, healthcare costs are a chief culprit in government budget shortfalls, and a growing portion of those costs are brain-related. A recent RAND Corporation ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo